SynRgee is a consulting company offering drug development and CMC consulting covering all phases of clinical development to assist biotech companies achieve optimal planning and execution of their drug development plans.

Ove Pedersen has +25 years of biotech experience in development and manufacture of drug substances (biologics, small molecules) and drug products (parenteral, solid dosage forms), as well as commercial and clinical trial material supply. He has held positions as Global Head of Product Development and Commercial Supply, ThromboGenics, VP of Development, Curalogic, and Director of Project Management, ALK-Abelló. Ove Pedersen holds a Ph.D. in organic chemistry from University of British Columbia, Canada.